BIOMAT Database Logo BIOMAT Database Logo

Effects of N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate on the ventriculo-atrial conductivity of accessory pathways. 1989

S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

The purpose of this study was to examine the effects of N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a newly developed antiarrhythmic agent belonging to class Ic, on the ventriculoatrial (VA) conductivity of accessory pathways and paroxysmal supra-ventricular tachycardia (PSVT). Twelve patients with accessory pathways were examined by standard electrophysiologic technique before and after a single oral dose of SUN 1165 (100 mg). 1 h after administration, SUN 1165 blocked VA conduction of the accessory pathway in six of twelve patients and prevented the induction of PSVT in six of seven cases. In the cases in which VA block did not occur, the VA interval prolonged (from 178 +/- 7 to 190 +/- 11 ms, p less than 0.05), and the effective refractory period of VA conduction was also increased (from 273 +/- 10 to 318 +/- 15 ms. p less than 0.05). SUN 1165 also prolonged the conduction time in normal conduction systems (AH and HV intervals and QRS duration), but the degree of the prolongation was moderate and not dangerous. There was no adverse effect. These results indicate that SUN 1165 is a potent and safe antiarrhythmic agent, and useful for preventing or stopping PSVT by blocking or depressing VA conduction through accessory pathways.

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009431 Neural Conduction The propagation of the NERVE IMPULSE along the nerve away from the site of an excitation stimulus. Nerve Conduction,Conduction, Nerve,Conduction, Neural,Conductions, Nerve,Conductions, Neural,Nerve Conductions,Neural Conductions
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
January 1985, Arzneimittel-Forschung,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
October 1988, Arzneimittel-Forschung,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
October 1988, Arzneimittel-Forschung,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
January 1985, Arzneimittel-Forschung,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
October 1988, Arzneimittel-Forschung,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
Effects of a new antiarrhythmic compound SUN 1165 [N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride] on the sodium currents in isolated single rat ventricular cells.
June 1984, Naunyn-Schmiedeberg's archives of pharmacology,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
Electrophysiological actions of N-(2,6-dimethylphenyl)-8-pyrrolizidine-acetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent.
January 1986, Journal of cardiovascular pharmacology,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
March 1992, Journal of cardiovascular pharmacology,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
Ventriculo-atrial conduction over accessory pathways exhibiting decremental properties.
June 1982, European heart journal,
S Satoh, and J Watanabe, and M Keitoku, and H Kinoshita, and N Sekiguchi, and S Endoh, and K Ohtsuka, and K Hangai, and M Morita, and T Takishima
2-[N-(2,3-Dimethylphenyl)carbamoyl]benzenesulfonamide and the 3,4- and 2,6-dimethylphenyl analogues.
July 2008, Acta crystallographica. Section C, Crystal structure communications,
Copied contents to your clipboard!